Agenda. A short introduction to Denmark. Background information about Faaborg Midtfyn Municipality. The NRR project. Our findings from the project

Size: px
Start display at page:

Download "Agenda. A short introduction to Denmark. Background information about Faaborg Midtfyn Municipality. The NRR project. Our findings from the project"

Transcription

1

2 Agenda A short introduction to Denmark Background information about Faaborg Midtfyn Municipality The NRR project Our findings from the project Future collaboration with Japan

3 Agenda A short introduction to Denmark Background information about Faaborg Midtfyn Municipality The NRR project Our findings from the project Future collaboration with Japan

4 A short introduction to Denmark Japan Population: 128 mio. Over 65 years of age: 19,7% Ranks 2nd for countries with the highest proportion of citizens over 65 Denmark Population: 5,4 mio. Over 65 years of age: 15,1% Ranks 22nd over countries with the highest proportion of citizens over 65

5 A short introduction to Denmark

6 A short introduction to Denmark Central Jutland Region IT-systems for healthcare sectors Pervasive healthcare North Jutland Region Develop medicine and medtech Intelligent assistive devices Automation and IT support functions South Jutland Region Intelligent assistive devices Telemedicine treatments Automation Health-IT-systems The Capital Region of Denmark Develop medicine and medtech Diagnostics clinical research 6

7 A short introduction to Denmark Working conditions: Short working day High labour productivity level Requires: High level of trust in employees Self-organised workers Clear and well-defined goals from management Accept that mistakes can happen, and that they can be fixed Share information 7

8 A short introduction to Denmark

9 A short introduction to Denmark Tax pressure: High tax pressure based on income frame: 39% - 55% VAT on all goods: 25% Company tax rate: 25% Life conditions: Free education Government support while unemployed Free access to doctors and hospitals 9

10 A short introduction to Denmark For Healthcare sector it is common practice to use the triple bottom line when assessing new methods or technologies: Avoid increased cost (profit) Stimulate growth in local businesses (Environment) Increase quality of life and service for the citizens and staff (Community) 10

11 Agenda A short introduction to Denmark Background information about Faaborg Midtfyn Municipality The NRR project Our findings from the project Future collaboration with Japan

12 Faaborg-Midtfyn Municipality Facts: citizens (36.228) 637 km2 (12 km2) employees 80 departements 9 professional divisions 4staff units Member of Welfare Tech Administration budget Total budget: 44 billion JPY

13 Faaborg-Midtfyn Municipality The Care Division of FMK provide: Practical and personal aid to citizens in their own homes Care for citizens in ursing homes / care facilities Home nursing No. of elderly recieving care 400 in nursing homes 1916 receives home care 1243 receives home nursing No. of employees 1057 No. of students/trainees 45/126 No. of units 30 Budget Price nursing home 5 billion JPY JPY/ day Meals on wheels for retired citiziens

14 Faaborg-Midtfyn Municipality Our strategy We wish to create an eco system that will: Provide good care for our elderly Offer good working environment for our staff Utilize latest technologies Participate in developing new technologies and soloutions in collaboration with private companies

15 Faaborg-Midtfyn Municipality We have visited Japan twice: In 2011: Osaka Noboribetsu In 2014: Tokyo NEDO DOCOMO Local technology companies Fukuoka area Vice Mayor of Fukkuoka TMSUK

16 Agenda A short introduction to Denmark Background information about Faaborg Midtfyn Municipality The NRR project Our findings from the project Future collaboration with Japan

17 The NRR project The participating partners

18 The NRR project Two test facilities in the municipality: Aaløkkeparken, Broby Manager: Lise-Lotte Steengaard 48 appartments Nørrevænget 1, Gislev Manager: Merete Jørgensen 46 appartments

19 The NRR project Science and research Business and Private companies Social system And government? 19

20 The NRR project The project ran through different phases: Initial evaluation of technology Identify test parameters Design test At university laboratories At municipality facilities Choose test persons Install technology Educate staff Carry out tests in two segments

21 Agenda A short introduction to Denmark Background information about Faaborg Midtfyn Municipality The NRR project Our findings from the project Future collaboration with Japan

22 Findings from NRR project Some elements of Danish care system are hard to explain. For example: The way we measure product quality in the Danish Health care system The features of an entirely publicly funded system The way we divide labor between staff and management

23 Findings from NRR project The planning of tests are quite different in Denmark and Japan. This influence: The types of results we reach The way we actually carry out the tests The amount of instruction neccesary for the staff

24 Findings from NRR project Danish people participate in special way: We often speak our minds We are very focused on solving problems We also have high ideals Our elderly people and staff like to particiapte in these types of test

25 Findings from NRR project Our understanding of authorities: A specialists opinion (eg. A doctor) is important, but not the ultimate truth We put faith in the opinions of those that actually carry out the work Caregivers Nurses The foremost expert is actually the patient/ elderly person

26 Findings from NRR project The percpetion of elderly people in Denmark: They should stay as long as possible in their own home being independent Activity is encouraged as much as possible Dignity in the late years is also a public task

27 Findings from NRR project In conclusion: New insights Evaluation of our model New ideas for the future Developed our own organization

28 We would like to thank:

29 Agenda A short introduction to Denmark Background information about Faaborg Midtfyn Municipality The NRR project Our findings from the project Future collaboration with Japan

30 Future collaboration with Japan Happy to test relevant technologies This can include: Provide manpower for test Provide access to care facilities Help plan and carry out test Provide sincere feedback on product relevance

31 Future collaboration with Japan Our goals for ourselves are to: Generate new knowledge Better understanding of our own way of providing care Expand our understanding of how technology can shape the future in care giving Find new products that can help us Save money Create a better working environment for our staff Provide better care / higher level of user satisfaction and independence

32 Future collaboration with Japan Our goals for our collaboration partners are to: Create a good place for Japanese companies to establish business or adapt their products through: Close collaboration with municipaliy Close to all major transportation Good availability of highly educated people

33 Thank you for your attention Michael Bech Petersen Manager of Digitization and Healthcare Technology Division Municipality of Faaborg-Midtfyn Denmark 2015 Powered by

Bupa Future Survey Series

Bupa Future Survey Series Bupa Future Survey Series March 2017 The future of private health insurance: Why insurers need to play a leading role in the innovation and transformation of Australia's health and care system The examines

More information

Guidelines for cost analyses of new medicines and indications in the hospital sector

Guidelines for cost analyses of new medicines and indications in the hospital sector Guidelines for cost analyses of new medicines and indications in the hospital sector 1 Table of contents 1. Introduction... 3 2. Guidelines for cost analyses of new medicines and new indications in the

More information

INSURANCE FOR THE HEALTHCARE INDUSTRY

INSURANCE FOR THE HEALTHCARE INDUSTRY INSURANCE FOR THE HEALTHCARE INDUSTRY YOUR WORLD, OUR KNOWLEDGE In your world, the patient comes first. Every minute of every day, you are focused on them. In our world, you come first. For more than half

More information

1. Introduction Executive Summary Market Survey Evaluation of Product/Market Suitability SWOT Analysis...

1. Introduction Executive Summary Market Survey Evaluation of Product/Market Suitability SWOT Analysis... Date June 2014 1. Introduction... 2 2. Executive Summary... 2 3. Market Survey... 3 4. Evaluation of Product/Market Suitability... 5 5. SWOT Analysis... 6 The Trade Council is pleased to submit a brief

More information

Ethical Rules for Collaboration between Patient Groups, etc. and the Pharmaceutical Industry

Ethical Rules for Collaboration between Patient Groups, etc. and the Pharmaceutical Industry Ethical Rules for Collaboration between Patient Groups, etc. and the Pharmaceutical Industry 1. Purpose The ethical rules create a framework for collaboration between the pharmaceutical industry and patient

More information

Standardisation of Health and Social Services

Standardisation of Health and Social Services Standardisation of Health and Social Services Position of the European Social Insurance Platform (ESIP) FINAL 14 July 2016 - 2 - About the European Social Insurance Platform (ESIP) The European Social

More information

NATIONAL SOCIAL REPORT Estonia

NATIONAL SOCIAL REPORT Estonia NATIONAL SOCIAL REPORT 2014 Estonia Table of contents Introduction... 3 A decisive impact on the eradication of poverty and social exclusion... 3 Recent reforms in social inclusion policies... 4 People

More information

Ethical Rules for Collaboration between Patient Organisations, etc., and the Pharmaceutical Industry

Ethical Rules for Collaboration between Patient Organisations, etc., and the Pharmaceutical Industry Ethical Rules for Collaboration between Patient Organisations, etc., and the Pharmaceutical Industry Art. 1. Purpose The ethical rules provides a framework for collaboration between the pharmaceutical

More information

OUTLINE Health Insurance System National Health Insurance Employee s Health Insurance Gakkenbai, Gakkensai Tokyo Tech Webpage & Health Support Center

OUTLINE Health Insurance System National Health Insurance Employee s Health Insurance Gakkenbai, Gakkensai Tokyo Tech Webpage & Health Support Center Tokyo Institute of Technology Hosted by the Office of Education and International Cooperation Japanese Medical System Daily Life Support Orientation For International Students and Researchers July 6, 2018

More information

REPORT ON DENMARK S APPLICATION OF THE COMMISSION DECISION OF 20 DECEMBER 2011 ON SERVICES OF GENERAL ECONOMIC INTEREST

REPORT ON DENMARK S APPLICATION OF THE COMMISSION DECISION OF 20 DECEMBER 2011 ON SERVICES OF GENERAL ECONOMIC INTEREST Logo: Ministry of Business and Growth Denmark REPORT ON DENMARK S APPLICATION OF THE COMMISSION DECISION OF 20 DECEMBER 2011 ON SERVICES OF GENERAL ECONOMIC INTEREST June 2016 2/14 CONTENTS Introduction

More information

Briefing: The EU Japan EPA and the European medical device market

Briefing: The EU Japan EPA and the European medical device market Briefing: The EU Japan EPA and the European medical device market In 2017 the EU and Japan signed the EU-Japan Economic Partnership Agreement. This trade agreement, which is expected to become effective

More information

DRG in Europe, esp. Germany

DRG in Europe, esp. Germany DRG in Europe, esp. Germany System overview and consequences for coding--- DRG-konferansen 5. 6. mars 2007 Oslo Dr. Michael Wilke Agenda 1 Rambøll Management 2 The German HealthCare System 3 4 DRG in Europe

More information

METHODOLOGY NOTES. TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO)

METHODOLOGY NOTES. TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO) METHODOLOGY NOTES TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO) Country of Disclosure: Belgium Year of Disclosure: 2017 for 2016

More information

FREQUENTLY ASKED QUESTIONS SUNSHINE ACT

FREQUENTLY ASKED QUESTIONS SUNSHINE ACT FREQUENTLY ASKED QUESTIONS SUNSHINE ACT 1. What exactly is the obligation of transparency? The obligation of transparency imposes amongst others pharmaceutical and medical devices companies, both Belgian

More information

INTERNATIONAL HEALTH SYSTEMS: THE ASIAN (TAIWAN, JAPAN, SINGAPORE,)

INTERNATIONAL HEALTH SYSTEMS: THE ASIAN (TAIWAN, JAPAN, SINGAPORE,) INTERNATIONAL HEALTH SYSTEMS: THE ASIAN (TAIWAN, JAPAN, SINGAPORE,) Presented by: Ms. Nuanthip Tangsitchanakun 5749173 Ms. Nan Nin Shwe Yi Lin 5849104 HEATH CARE SYSTEMS JAPAN IN OVERVIEW OF JAPAN HEALTHCARE

More information

FREQUENTLY ASKED QUESTIONS SUNSHINE ACT

FREQUENTLY ASKED QUESTIONS SUNSHINE ACT FREQUENTLY ASKED QUESTIONS SUNSHINE ACT 1. What exactly is the obligation of transparency? The obligation of transparency imposes pharmaceutical and medical devices companies, both Belgian and foreign,

More information

BERMUDA HEALTH INSURANCE DEPARTMENT ANNUAL REPORT

BERMUDA HEALTH INSURANCE DEPARTMENT ANNUAL REPORT BERMUDA HEALTH INSURANCE DEPARTMENT ANNUAL REPORT YOUR HEALTH MATTERS Welcome to the Health Insurance Department s first annual report for policyholders of FutureCare and the Health Insurance Plan ( HIP

More information

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 AstraZeneca Österreich GmbH Landstraßer Hauptstraße 1A, 1030 Wien Firmenbuch FN 51184x, HG Wien Contents

More information

Scope of Practice & Compensation Report for the Regulatory Profession

Scope of Practice & Compensation Report for the Regulatory Profession 2014 Scope of Practice & Compensation Report for the Regulatory Profession 2014 Scope of Practice & Compensation Report for the Regulatory Profession 1 Contents Introduction... 2 About RAPS... 2 The Survey:

More information

METHODOLOGY NOTES. TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO)

METHODOLOGY NOTES. TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO) METHODOLOGY NOTES TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO) Country of Disclosure: Ireland Year of Disclosure: 2018 for 2017

More information

Lithuania. How does the country rank in the EU? Health. Overall Findings. Need Lithuania has a high need for policy reform, assessed by the experts

Lithuania. How does the country rank in the EU? Health. Overall Findings. Need Lithuania has a high need for policy reform, assessed by the experts Findings by Country How does the country rank in the EU? Health Poverty Prevention Best Median Worst Social Cohesion and Non-discrimination Equitable Education Labour Market Access Social Justice Index

More information

IICCI Short Market Overviews. The Healthcare Industry in India

IICCI Short Market Overviews. The Healthcare Industry in India The Healthcare Industry in India 1. The Healthcare Industry In India healthcare is delivered through both the public sector and private sector. The public healthcare system consists of healthcare facilities

More information

WELCOME TO GROUP CRITICAL ILLNESS

WELCOME TO GROUP CRITICAL ILLNESS WELCOME TO GROUP CRITICAL ILLNESS THANK YOU Thank you for choosing Canada Life Group Insurance Thank you for choosing us to provide Group Critical Illness cover for you and your employees. We provide more

More information

METHODOLOGY NOTES. TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO)

METHODOLOGY NOTES. TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO) METHODOLOGY NOTES TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO) Country of Disclosure: Austria Year of Disclosure: 2018 for 2017

More information

Legal grounds Act LXV of 1990 on Local Governments (hereinafter referred to as Local Government Act)

Legal grounds Act LXV of 1990 on Local Governments (hereinafter referred to as Local Government Act) Magdolna Berenyi Financial audit of local government institutions providing services to the homeless in Hungary Homelessness terms The homelessness has existed for thousand years and since the beginning

More information

Birth Age

Birth Age Social security system supporting people throughout their lifetime Birth Age 6 12 15 18 20 40 50 60 70 75 Before school School period Child-raising/working period After retirement [Health/medical care]

More information

Universal and Equal Access to Health-care Services. Štefan Krajčík Slovak Medical University Bratislava, Slovakia

Universal and Equal Access to Health-care Services. Štefan Krajčík Slovak Medical University Bratislava, Slovakia Universal and Equal Access to Health-care Services Štefan Krajčík Slovak Medical University Bratislava, Slovakia Universal and Equal Access to Health-care Services Member States of the World Health Organization

More information

METHODOLOGY NOTES. TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO)

METHODOLOGY NOTES. TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO) METHODOLOGY NOTES TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO) Country of Disclosure: United Kingdom Year of Disclosure: 2017

More information

Hong Kong Women Professionals & Entrepreneurs Association (HKWPEA) Public Affairs Committee

Hong Kong Women Professionals & Entrepreneurs Association (HKWPEA) Public Affairs Committee Hong Kong Women Professionals & Entrepreneurs Association (HKWPEA) Public Affairs Committee Response Paper to the Review of Enhancement of Retirement Protection as proposed by the Commission on Poverty

More information

AstraZeneca AB Södertälje. Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2015 Data in 2016

AstraZeneca AB Södertälje. Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2015 Data in 2016 AstraZeneca AB 556011-7482 151 85 Södertälje Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2015 Data in 2016 Contents 1. Introduction... 4 Approach to disclosure

More information

INTERIM REPORT Q2 JANUARY JUNE 2017

INTERIM REPORT Q2 JANUARY JUNE 2017 1 INTERIM REPORT Q2 JANUARY JUNE 2017 WE LIVE LONGER THAN EVER BEFORE BUT FEW OF US REMAIN COMPLETELY HEALTHY THROUGHOUT LIFE In the last 25 years, medication has increased significantly among the elderly.

More information

Chapter 2 Overview of Social Security in Japan

Chapter 2 Overview of Social Security in Japan Security in Japan 2014 2.1 History of the social security system in Japan 2.1.1 Pre-Modern Era (before 1868) As with other countries, the source of social security in Japan could be found in charity-oriented

More information

A Discrete Event Simulation Model for Outpatient Appointment Scheduling

A Discrete Event Simulation Model for Outpatient Appointment Scheduling A Discrete Event Simulation Model for Outpatient Appointment Scheduling Michelle Alvarado, PhD Mark Lawley, PhD Yan Li, PhD Industrial and Systems Engineering, Texas A&M University New York Academy of

More information

Healthcare System Innovation for Aging Society -Issues and Direction-

Healthcare System Innovation for Aging Society -Issues and Direction- Healthcare System Innovation for Aging Society -Issues and Direction- APEC Life Sciences Innovation Forum Health Financing Mechanisms & Options Sep. 19, 2010 Prof. Akira Morita University of Tokyo 2010

More information

Medicines for Europe (MFE) HCP/HCO/PO Disclosure Transparency Requirements. Samsung Bioepis Methodology Note

Medicines for Europe (MFE) HCP/HCO/PO Disclosure Transparency Requirements. Samsung Bioepis Methodology Note Medicines for Europe (MFE) HCP/HCO/PO Disclosure Transparency Requirements Samsung Bioepis Methodology Note 1 Contents 1. Overview of the MFE Requirements 2. Decisions 3. Submission Requirements 4. Categories

More information

Financial strategies for the healthcare industry

Financial strategies for the healthcare industry Financial strategies for the healthcare industry Financial strategies for the healthcare industry In an ever-changing industry, you need a financial partner who understands your unique needs and enables

More information

DANISH MINISTRY OF BUSINESS AND GROWTH

DANISH MINISTRY OF BUSINESS AND GROWTH DANISH MINISTRY OF BUSINESS AND GROWTH REPORT ON DENMARK S APPLICATION OF THE COMMISSION DECISION OF 20 DECEMBER 2011 CONCERNING THE OPERATION OF SERVICES OF GENERAL ECONOMIC INTEREST (SGEI) June 2014

More information

CARING FOR YOUR SMALL BUSINESS. Off-Exchange 2018 Plans and Services for Groups With Up to 100 Employees

CARING FOR YOUR SMALL BUSINESS. Off-Exchange 2018 Plans and Services for Groups With Up to 100 Employees CARING FOR YOUR SMALL BUSINESS Off-Exchange 2018 Plans and Services for Groups With Up to 100 Employees SMALL GROUP PLANS AT A GLANCE EmblemHealth offers small group plans with the needs and budgets of

More information

Insurance Technology and Longevity Risk. Jennifer Li-Ling Wang Vice President of National Chenghgchi University Chairman of Fintech Research Center

Insurance Technology and Longevity Risk. Jennifer Li-Ling Wang Vice President of National Chenghgchi University Chairman of Fintech Research Center Insurance Technology and Longevity Risk Jennifer Li-Ling Wang Vice President of National Chenghgchi University Chairman of Fintech Research Center The Impact of InsurTech WEF FinTech report in 2015 state

More information

COMPANY. Product Summary From 1 April bupa.com.au

COMPANY. Product Summary From 1 April bupa.com.au COMPANY Product Summary From 1 April 2017 bupa.com.au Bupa international private medical insurance is underwritten in Australia by Insurance Australia Limited ABN 11 000 016 722 (IAL), AFSL number 227681.

More information

Healthcare. The role of real estate. June 2014

Healthcare. The role of real estate. June 2014 1 Healthcare The role of real estate June 2014 2 Background 1. The British Property Federation (BPF) is the voice of real estate in the UK, representing businesses owning, managing and investing in real

More information

The Impact of Future Healthcare Reform on MedTech Communications

The Impact of Future Healthcare Reform on MedTech Communications J. Robert Paulson President & CEO NxThera, Inc. The Impact of Future Healthcare Reform on MedTech Communications Perspectives From an Early-Stage Medical Device Company The Impact of Future Healthcare

More information

Business Results for The First Half of FY2018 (April 1, 2018 September 30, 2018) November 1, 2018

Business Results for The First Half of FY2018 (April 1, 2018 September 30, 2018) November 1, 2018 Business Results for The First Half of FY2018 (April 1, 2018 September 30, 2018) November 1, 2018 Please be aware of the following: * The financial information provided on this material has been prepared

More information

Adding value to the Bancassurance Offer, Trends and Initiatives from an Assistance Company Perspective. Warsaw, 24th of October 2013

Adding value to the Bancassurance Offer, Trends and Initiatives from an Assistance Company Perspective. Warsaw, 24th of October 2013 Adding value to the Bancassurance Offer, Trends and Initiatives from an Assistance Company Perspective Warsaw, 24th of October 2013 Table of contents 1. The Assistance Concept 2. Added Value for Bancassurance

More information

MedTech Europe Code of Ethical Business Practice. Disclosure Guidelines

MedTech Europe Code of Ethical Business Practice. Disclosure Guidelines MedTech Europe Code of Ethical Business Practice Disclosure Guidelines Final version: 13 September 2016 Table of Contents Preamble... 2 Chapter 1: Applicability of these Guidelines... 3 1. Scope... 3 2.

More information

Methodology for Compliance with the Research-Based Pharmaceutical Industry (LIF) Disclosure Code

Methodology for Compliance with the Research-Based Pharmaceutical Industry (LIF) Disclosure Code Methodology for Compliance with the Research-Based Pharmaceutical Industry (LIF) Disclosure Code Date Published: 31 May 2017 Index Annex 1: The disclosure in accordance with the Schedule 2 Template Annex

More information

This little Piggy likes questions! FAQ Guide

This little Piggy likes questions! FAQ Guide This little Piggy likes questions! FAQ Guide A guide to some of the most frequently asked questions related to health spending accounts and some additional tips smart folks should know. Table of Contents

More information

Education, training, life-long learning and capacity-building

Education, training, life-long learning and capacity-building Education, training, life-long learning and capacity-building 1. In your country/region, how is the right to education, training, life-long learning and capacity building in

More information

Gilead Transparency Reporting Methodological Note

Gilead Transparency Reporting Methodological Note Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers

More information

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 AstraZeneca Bulgaria EOOD Registration number 201340239 36 Dragan Tsankov, Bulgaria, Sofia1057 Contents

More information

Methodology for Compliance with the ABPI Disclosure Code. Introduction Page 1. General Comments Page 2. Indirect Transfers of Value Page 3

Methodology for Compliance with the ABPI Disclosure Code. Introduction Page 1. General Comments Page 2. Indirect Transfers of Value Page 3 Date Published: 15 th March 2017 Version: 20 (December 4, 2015) Index Methodology for Compliance with the ABPI Disclosure Code Introduction Page 1 General Comments Page 2 Indirect Transfers of Value Page

More information

ARPIM HCP/HCO DISCLOSURE CODE

ARPIM HCP/HCO DISCLOSURE CODE ARPIM HCP/HCO DISCLOSURE CODE ARPIM CODE ON THE DISCLOSURE OF SPONSORSHIPS AND OTHER TRANSFERS OF VALUE FROM PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO)

More information

Long-term care Dilemmas concerning sustainable financing (Ljubljana, November 2014) 1

Long-term care Dilemmas concerning sustainable financing (Ljubljana, November 2014) 1 Long-term care Dilemmas concerning sustainable financing (Ljubljana, 18-19 November 2014) 1 Heino Jespersen The National Social Appeals Board This paper briefly describes the organisation and funding of

More information

SESSIONS MASTERCLASS A - 29/01/2018. Healthcare Insurance Forum

SESSIONS MASTERCLASS A - 29/01/2018. Healthcare Insurance Forum MASTERCLASS A - 29/01/2018 Building a Winning Digital Strategy for your Organisation 08:00-12:00 The world is increasingly connected through technology changing the way people think and the way business

More information

Gilead Transparency Reporting Methodological Note

Gilead Transparency Reporting Methodological Note Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers

More information

IBFD Course Programme Transfer Pricing: Financial Services Industry Masterclass

IBFD Course Programme Transfer Pricing: Financial Services Industry Masterclass IBFD Course Programme Transfer Pricing: Financial Services Industry Overview and Learning Objectives Digitalization has changed and will continue to change business models. This will impact the global

More information

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 AstraZeneca Eesti OÜ Reg. kood 11733875 Järvevana tee 9 11314 Tallinn Estonia Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 Contents 1. Introduction...

More information

Gilead Transparency Reporting Methodological Note

Gilead Transparency Reporting Methodological Note Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers

More information

Health System and Policies of China

Health System and Policies of China of China Yang Cao, PhD Associate Professor China Pharmaceutical University Nanjing, China Transformation of Healthcare Delivery in China Medical insurance 1 The timeline of the medical and health system

More information

LIKE YOU, WE RE EXPERTS IN OUR FIELD

LIKE YOU, WE RE EXPERTS IN OUR FIELD Administered by MARITIME SHIPPING LIKE YOU, WE RE EXPERTS IN OUR FIELD Insured by Health nsurance Raffles Health Insurance Pte Ltd, (Company Registration No: 200413569G), 133 Middle Road, Bank of China

More information

Dr. Robert Riehle Jr. Wofford College 2/24/10

Dr. Robert Riehle Jr. Wofford College 2/24/10 Dr. Robert Riehle Jr. Wofford College 2/24/10 Wofford Healthcare Symposium Our current system and its need to change Financing of the delivery system Components of an ideal delivery system What change

More information

GLOBAL HEALTH PARTNER Q4 REPORT Daniel Öhman, CEO Tobias Linebäck, CFO and Dep. CEO

GLOBAL HEALTH PARTNER Q4 REPORT Daniel Öhman, CEO Tobias Linebäck, CFO and Dep. CEO REPORT Daniel Öhman, CEO Tobias Linebäck, CFO and Dep. CEO performance CEO comments Agenda and Full year financials Summary and future Improved performance in SEK millions REVENUES Revenues at 208 (206)

More information

COMMISSION DECISION. of

COMMISSION DECISION. of EUROPEAN COMMISSION Brussels, 25.11.2016 C(2016) 7553 final COMMISSION DECISION of 25.11.2016 modifying the Commission decision of 7.3.2014 authorising the reimbursement on the basis of unit costs for

More information

What else could you do with the time you spend on budgeting?

What else could you do with the time you spend on budgeting? What else could you do with the time you spend on budgeting? Budgeting As your company evolves, you have to devote more and more time to preparing your budgets. That s why Prophix brings you. This Best

More information

This DataWatch provides current information on health spending

This DataWatch provides current information on health spending DataWatch Health Spending, Delivery, And Outcomes In OECD Countries by George J. Schieber, Jean-Pierre Poullier, and Leslie M. Greenwald Abstract: Data comparing health expenditures in twenty-four industrialized

More information

Sheryl T. Dacso, J.D., Dr.P.H.

Sheryl T. Dacso, J.D., Dr.P.H. Highlights of the New Health Care Reform and its Impact on the Legal Industry Presented to the Houston Metropolitan Paralegal Association November 9, 2010 Sheryl T. Dacso, J.D., Dr.P.H. sdacso@seyfarth.com

More information

AstraZeneca AB Södertälje. Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018

AstraZeneca AB Södertälje. Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 AstraZeneca AB 556011-7482 151 85 Södertälje Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 Contents 1. Introduction... 4 Approach to disclosure

More information

Sanofi-Aventis Bulgaria EOOD Methodological Note

Sanofi-Aventis Bulgaria EOOD Methodological Note Sanofi-Aventis Bulgaria EOOD Methodological Note INTRODUCTION Collaboration between healthcare professionals and Pharmaceutical Companies has long been a positive driver for advancements in patient care

More information

Gilead Transparency Reporting Methodological Note

Gilead Transparency Reporting Methodological Note Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers

More information

Challenges of implementation. a regulatory perspective

Challenges of implementation. a regulatory perspective Challenges of implementation of ICH Q 9 a regulatory perspective Jacques Morénas Deputy Director Inspectorate and Companies Department The French Health Products Safety Agency (AFSSAPS) telephone : 33

More information

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 NV ASTRAZENECA SA BE 0400.165.679 110, rue Egide Van Ophemstraat B-1180 Brussels Belgium Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 Contents

More information

Your Global Partner in International Private Medical Insurance. Expatriate Care Playbook

Your Global Partner in International Private Medical Insurance. Expatriate Care Playbook Your Global Partner in International Private Medical Insurance Expatriate Care Playbook AT A GLANCE 95+ Years in operation 90M Clients served by AIG companies 99.6% Fortune 500 companies AIG serves ~65,000

More information

Initial Functional Medicine (FM) Consult $475 FM follow up visits $175 Convenient Care Visit $125. Action Plan/Health Care Consult Visit $50

Initial Functional Medicine (FM) Consult $475 FM follow up visits $175 Convenient Care Visit $125. Action Plan/Health Care Consult Visit $50 Cash, checks, credit cards (MasterCard, Visa, Discover) or Care Credit* are all accepted methods of payment for our services. Payment is due, in full, at the time of the scheduled appointment. When you

More information

MGMA National MGMA18 The Annual Conference September, 2018 Attendee Form

MGMA National MGMA18 The Annual Conference September, 2018 Attendee Form MGMA National MGMA18 The Annual Conference September, 2018 Attendee Form Title CEU Code CEUs Specialty MGMA18 The Annual Conference-PRE102 Designing and Building Processes for Value-based Healthcare 5

More information

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 AstraZeneca UK Limited Registered in England No 3674842 Registered Office, 2 Kingdom Street, London,

More information

Your Company guide to a healthier future

Your Company guide to a healthier future Bupa PO Box 825 Hawthorn Victoria 3122 www.bupa.com.au Global medical plans for individuals and groups Assistance, repatriation and evacuation cover 24-hour multi-lingual helpline Your Company guide to

More information

Medicare Made Clear Answer Guide

Medicare Made Clear Answer Guide Medicare Made Clear Answer Guide Y0066_100820_113217 File & Use 08252010 Medicare can be confusing. How do you find the best options to fit your needs? This guide has some answers that may be helpful.

More information

Note: Accredited is the highest rating an exchange product can have for 2015.

Note: Accredited is the highest rating an exchange product can have for 2015. Quality Overview Permanente Accreditation Exchange Product Accrediting Organization: NCQA HMO (Exchange) Accreditation Status: Accredited Note: Accredited is the highest rating an exchange product can

More information

The Florida International University Budget Town Hall Discussion. March 9, 2009

The Florida International University Budget Town Hall Discussion. March 9, 2009 The Florida International University Budget Town Hall Discussion March 9, 2009 1 FLORIDA INTERNATIONAL UNIVERSITY AGENDA Direction What is the University s strategic direction? What are the state revenue

More information

Situation Regarding Implementation of Measures for the Aging Society. Fundamental Framework of Measures for the Aging Society

Situation Regarding Implementation of Measures for the Aging Society. Fundamental Framework of Measures for the Aging Society Chapter 2 Situation Regarding Implementation of Measures for the Aging Society Section 1 Fundamental Framework of Measures for the Aging Society The basic framework of national measures for the aging society

More information

ANNUAL GENERAL MEETING

ANNUAL GENERAL MEETING Virtus Health (ASX. VRT) ANNUAL GENERAL MEETING Wednesday 22nd November 2017 2.00pm AEDT DISCLAIMER The material in this presentation has been prepared by Virtus Health Limited ABN 80 129 643 492 ( Virtus

More information

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 LLC «AstraZeneca Ukraine» Legal address: Kyiv, Hvoiky str. 15/15,04080 Ukraine Actual address: Kyiv,

More information

Board s corporate objectives for outline a requirement to provide best value for resources and deliver financial balance.

Board s corporate objectives for outline a requirement to provide best value for resources and deliver financial balance. Board Paper 2016/47 Shetland NHS Board Meeting: Shetland NHS Board Date: 4 th October 2016 Paper Title: Finance monitoring report (2016-17) to 31 August 2016 Author: Colin Marsland Job Title: Director

More information

Cigna. Confirmed complaints: 5. Quality Overview. How Often Do Members Complain About This Company? Accreditation Exchange Product

Cigna. Confirmed complaints: 5. Quality Overview. How Often Do Members Complain About This Company? Accreditation Exchange Product Quality Overview Accreditation Exchange Product Accrediting Organization: NCQA Health Plan Accreditation (Exchange) Accreditation Status: Pending (214) Accreditation Commercial Product Accreditation Organization:

More information

Being unprepared for a medical emergency can cost you thousands of $$ out of pocket.

Being unprepared for a medical emergency can cost you thousands of $$ out of pocket. Health Insurance 101 - By Linda Ziac The Caregiver Resource Center www.caregiverresourcecenter.com Being unprepared for a medical emergency can cost you thousands of $$ out of pocket. es by that there

More information

Toshihiko Osada General Manager, Strategic Planning Department. Corporate Strategy. Terumo Corporation Dec 12, 2016

Toshihiko Osada General Manager, Strategic Planning Department. Corporate Strategy. Terumo Corporation Dec 12, 2016 2 Toshihiko Osada General Manager, Strategic Planning Department Corporate Strategy Outlook: Medtech Industry Global medtech market: Forecast to grow at a CAGR of 5-6% for the next 10 years, with market

More information

CMIC HOLDINGS Co., Ltd. Consolidated Financial Results

CMIC HOLDINGS Co., Ltd. Consolidated Financial Results (Note) This translation is prepared and provided for readers' convenience only. In the event of any discrepancy between this translated document and the original Japanese document, the original document

More information

Content. 05 May Memorandum. Ministry of Health and Social Affairs Sweden. Strategic Social Reporting 2015 Sweden

Content. 05 May Memorandum. Ministry of Health and Social Affairs Sweden. Strategic Social Reporting 2015 Sweden Memorandum 05 May 2015 Ministry of Health and Social Affairs Sweden Strategic Social Reporting 2015 Sweden Content 1. Introduction... 2 2. Delivering on the Europe 2020 objective to combat poverty and

More information

DIGITAL TRANSFORMATION ROLE IN REALIZING THE SUSTAINABLE DEVELOPMENT IN EGYPT

DIGITAL TRANSFORMATION ROLE IN REALIZING THE SUSTAINABLE DEVELOPMENT IN EGYPT DIGITAL TRANSFORMATION ROLE IN REALIZING THE SUSTAINABLE DEVELOPMENT IN EGYPT CSTD Inter-Sessional Panel Meeting The impact of rapid technological change on sustainable development Vienna, 15-19 January,

More information

OPENING REMARKS BY SENATOR HUBERT H. HUMPHREY MAGAZINE PUBLISHERS ASSOCIATION WASHINGTON, D. C. MAY 14, :30 P.M. this is a necessary

OPENING REMARKS BY SENATOR HUBERT H. HUMPHREY MAGAZINE PUBLISHERS ASSOCIATION WASHINGTON, D. C. MAY 14, :30 P.M. this is a necessary OPENING REMARKS BY SENATOR HUBERT H. HUMPHREY MAGAZINE PUBLISHERS ASSOCIATION WASHINGTON, D. C. MAY 14, 1962--2:30 P.M. I am here to speak for the Adminis- ~ tration's health insurance, hospital care pro~ram

More information

HEALTHCARE: INTRODUCTION MAIN ISSUES IDENTIFIED BY THE COMMITTEE:

HEALTHCARE: INTRODUCTION MAIN ISSUES IDENTIFIED BY THE COMMITTEE: HEALTHCARE: The Future of Health in Estonia Multi-Sector Collaboration to Ensure Proper Business Climate, Healthy Workforce, and Attractiveness for Current & Future Investment INTRODUCTION The Estonian

More information

Daniel E. Chornous Chief Investment Officer, RBC Global Asset Management

Daniel E. Chornous Chief Investment Officer, RBC Global Asset Management t Membership Guide Testimonials The RIA is a leader in promoting the responsible investment industry in Canada as well as providing invaluable education and research on responsible investing issues. RBC

More information

INDUSTRY PROFILES. Health Care and Social Assistance Industry

INDUSTRY PROFILES. Health Care and Social Assistance Industry INDUSTRY PROFILES Health Care and Social Assistance Industry July 2010 Overview: The Health Care and Social Assistance industry 1 in Alberta includes establishments and services such as: hospitals, nursing

More information

PAYING FOR THE HEALTHCARE WE WANT

PAYING FOR THE HEALTHCARE WE WANT PAYING FOR THE HEALTHCARE WE WANT MARK STABILE 1 THE PROBLEM Well before the great recession of 2008, Canada s healthcare system was sending out signals that it had a financing problem. Healthcare costs

More information

Federal and State Transparency Meeting Obligations and Managing Risks

Federal and State Transparency Meeting Obligations and Managing Risks Federal and State Transparency Meeting Obligations and Managing Risks Trudy Seeley, Sanofi US Diane Bieri, Arnold & Porter Sixth Annual Summit on Disclosure, Transparency and Aggregate Spend February 6,

More information

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 AstraZeneca Pharma Poland Sp. z o.o. 0000117902 Postepu 14, 02-676 Warsaw Contents 1. Introduction...

More information

Board s corporate objectives for outline a requirement to provide best value for resources and deliver financial balance.

Board s corporate objectives for outline a requirement to provide best value for resources and deliver financial balance. Board Paper 2017/04 Shetland NHS Board Meeting: Shetland NHS Board Date: 14 February 2017 Paper Title: Finance monitoring report (2016-17) to 31 December 2016 Author: Colin Marsland Job Title: Director

More information

Building the Healthcare System of the Future O R A C L E W H I T E P A P E R F E B R U A R Y

Building the Healthcare System of the Future O R A C L E W H I T E P A P E R F E B R U A R Y Building the Healthcare System of the Future O R A C L E W H I T E P A P E R F E B R U A R Y 2 0 1 7 Introduction Healthcare in the United States is changing rapidly. An aging population has increased

More information

Code of Conduct Medical Devices

Code of Conduct Medical Devices Code of Conduct Medical Devices - 1st January 2012 last amended January 2018 Code of Conduct Medical Devices This translation is not legally binding. Where contradictions occur between the Dutch and English

More information

How To Make Your Financial Plan CPA Strong

How To Make Your Financial Plan CPA Strong How To Make Your Financial Plan CPA Strong 11457B-302_CFF Revised CPA Brochure-PS.indd 1 Why Work With a CPA Financial Planner? Because the person who does your financial planning must also underst the

More information